UK Government And Industry Still Far Apart In Talks on New Pricing Scheme
Executive Summary
The UK pharmaceutical industry association, the ABPI, says it and the government are still far from reaching a deal on a new voluntary pricing agreement and has suggested that a transition to the statutory scheme could be on the cards if an acceptable deal cannot be secured.